Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. FI: 55.87

Farnier M Robinson JG, ODYSSEY LONG TERM Investigators, Maria Assumpta Caixas Pedragos

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	1489-1499
Journal	The New England Journal of Medicine
Volume	372
Issue number	16
Publication status	Published - 1 Jan 2015

Cite this

@article{e83c21ac54bd47faa7b815152534d9af,

title = "Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. FI: 55.87",

author = "{Robinson JG}, {Farnier M} and Investigators, {ODYSSEY LONG TERM} and {Caixas Pedragos}, {Maria Assumpta}",

year = "2015",

month = jan,

day = "1",

language = "English",

volume = "372",

pages = "1489--1499",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "16",

}

TY - JOUR

T1 - Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. FI: 55.87

AU - Robinson JG, Farnier M

AU - Investigators, ODYSSEY LONG TERM

AU - Caixas Pedragos, Maria Assumpta

PY - 2015/1/1

Y1 - 2015/1/1

M3 - Article

VL - 372

SP - 1489

EP - 1499

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 16

ER -